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Summary
p120-catenin is an Arm repeat protein that interacts
with variedcomponents such as cadherin, smallGpro-
teins, kinases, and the Kaiso transcriptional repres-
sor. Despite recent advances in understanding the
roles that p120-catenin and Kaiso play in downstream
modulation of Wnt/b-catenin signaling, the identity of
the upstream regulators of the p120-catenin/Kaiso
pathway have remained unclear. Here, we find that
p120-catenin binds Frodo, which itself interacts with
the Wnt pathway protein Dishevelled (Dsh). In Xeno-
pus laevis, we demonstrate that Wnt signals result in
Frodo-mediated stabilization of p120-catenin, which,
in turn, promotes Kaiso sequestration or removal
from the nucleus. Our results point to Dsh and Frodo
as upstream regulators of the p120-catenin/Kaiso sig-
naling pathway. Importantly, this suggests that Wnt
signals acting through Dsh regulate the stability of
p120-catenin in addition to that of b-catenin, and that
each catenin promotes its respective signal in parallel
to regulate distinct, as well as shared, direct down-
stream gene targets.
Introduction
Canonical Wnt signals are mediated through b-catenin/
TCF/LEF (Wnt/b-catenin pathway), whereas Wnt/PCP
signals are mediated through Rho GTPases or other in-
termediates. Each pathway and their interplay are fun-
damental to a wide array of developmental processes
as well as tumor progression (Logan and Nusse, 2004;
Moon et al., 2004). Wnt/b-catenin pathway activation
leads to b-catenin’s metabolic stabilization and gener-
ally involves multiple components such as Wnt extra-
cellular ligand, transmembrane Fz (Frizzled) receptor
and LRP (Low-Density Lipoprotein-Related) coreceptor,
and intracellular Dsh (Dishevelled). Stabilized b-catenin
enters the nucleus and interacts with DNA-binding tran-
scriptional repressors of the TCF/LEF (hereafter called
*Correspondence: pdmccrea@mdanderson.orgthe TCF) family, resulting in the activation (relief of
repression) of downstream target genes (Logan and
Nusse, 2004; Moon et al., 2004). b-catenin’s signaling
activity is further modulated by other cytoplasmic deter-
minants (Gottardi and Gumbiner, 2004) and by a variety
of nuclear cofactors (Logan and Nusse, 2004).
Catenins (excepting a-catenin) contain central Arma-
dillo (Arm) repeats facilitating direct association with
cadherin cell-cell adhesion proteins, with modulators
or components of the cytoskeleton, and with assorted
other polypeptides such as transcriptional repressors,
involved in developmental and pathologic gene regula-
tion. Catenin family proteins include the well-studied
b-catenin, its close homolog plakoglobin (g-catenin),
and the similar but not as closely related p120-catenin
subfamily members. Catenins participate in an array of
processes spanning the areas of cell adhesion, migra-
tion and cytoskeletal function, survival and proliferation,
and cell differentiation and apoptosis (Anastasiadis and
Reynolds, 2000; Gottardi and Gumbiner, 2001; Hatzfeld,
2005; Reynolds and Roczniak-Ferguson, 2004; van Roy
and McCrea, 2005).
p120-catenin was first characterized as a favored Src
and receptor tyrosine kinase substrate (Reynolds et al.,
1992, 1994), and it later became recognized as the
founding member of the p120 subclass that additionally
includes ARVCF, d-catenin, and p0071 (Anastasiadis and
Reynolds, 2000). While both b-catenin and p120-catenin
bind cadherin cytoplasmic domains, p120-catenin sub-
family members associate with the more membrane-
proximal region implicated in cadherin dimerization and
adhesive/motility functions as well as in cadherin en-
docytosis and metabolic stability (Davis et al., 2003;
Reynolds and Roczniak-Ferguson, 2004). p120-catenin
has additionally been found bound to kinesin and micro-
tubules (Franz and Ridley, 2004; Yanagisawa et al.,
2004), and considerable attention has also been focused
on its key roles in modulating Rho GTPases and,
thereby, cytoskeletal and cell cycle functions (Anasta-
siadis et al., 2000; Anastasiadis and Reynolds, 2001;
Ohkubo and Ozawa, 1999; Yanagisawa et al., 2004).
Also, tissue-specific knockout studies of p120-catenin
in mice, as well as knockdown approaches in Xenopus,
have supported p120-catenin’s essential developmen-
tal roles in cadherin and Rho GTPase modulation
(Ciesiolka et al., 2004; Davis and Reynolds, 2006; Elia
et al., 2006; Fang et al., 2004; Perez-Moreno et al., 2006).
Further insights into p120-catenin’s developmental
functions have come from studies of its direct involve-
ment in relieving Kaiso-mediated gene repression (Kim
et al., 2004; Park et al., 2005). While less well understood
than b-catenin-directed activation of Wnt gene targets
(through relief of TCF/LEF-mediated repression) (Daniels
and Weis, 2005), p120-catenin relieves Kaiso-mediated
repression of genes likewise active within developmen-
tal and pathologic contexts (Kim et al., 2004; Park et al.,
2005; Spring et al., 2005). Indeed, in certain cases, the
Kaiso repressor has been shown to bind Kaiso consen-
sus sites within promoter regions also harboring func-
tional TCF sites (Wnt/b-catenin gene targets). In such
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thought to occur through the respective actions of
p120- and b-catenin. The mechanism of b-catenin relief
of TCF-mediated repression appears to be different
from that of p120-catenin-directed relief of Kaiso, in
which the latter repressor is thought to be displaced
from promoter DNA upon p120-catenin association
(Kim et al., 2004; Park et al., 2005; Spring et al., 2005).
Despite such distinctions, it appears that limited paral-
lels may be drawn between the b-catenin/TCF and
p120-catenin/Kaiso pathways and their shared down-
stream actions on certain gene targets.
Kaiso was first identified in association with p120-cat-
enin (Daniel and Reynolds, 1999), and it belongs to the
BTB/POZ (Broad complex, Tramtrak, Bric a` brac/POx
virus and Zinc finger) family of proteins (Bardwell and
Treisman, 1994). BTB/POZ proteins contain an N-termi-
nal POZ domain that engages in protein-protein inter-
actions (dimerization and corepressor interactions)
and a C-terminal (C2H2) zinc finger domain responsible
for DNA association (Albagli et al., 1995; Bardwell and
Treisman, 1994). Among the BTB/POZ proteins, Kaiso
appears to be unique in possessing dual specificity,
recognizing both sequence-specific consensus sites
and methylated CpG dinucleotides (Daniel et al., 2002;
Prokhortchouk et al., 2001; Ruzov et al., 2004; Yoon
et al., 2003).
Recently, it was reported that p120-catenin and Kaiso
modulate sequence-specific gene targets that include
Wnt-11, Siamois, Matrilysin, Rapsyn, and S1004A (De-
fossez et al., 2005; Kim et al., 2004; Park et al., 2005; Ro-
dova et al., 2004; Ruzov et al., 2004; Spring et al., 2005;
Yoon et al., 2003). As noted, a number of these genes
are also directly responsive to Wnt/b-catenin signals
(Gumbiner, 2005; Kim et al., 2004; Park et al., 2005).
Thus, while likely to regulate distinct gene targets in
many cases, it appears that numerous coregulated
genes exist where parallel p120- and b-catenin path-
ways converge within the nucleus. An important remain-
ing question that we have addressed in this study re-
gards the mechanism of upstream p120-catenin/Kaiso
pathway regulation, which, for example, might be initi-
ated at the plasma membrane in response to ligand:
receptor interactions.
Frodo (Functional regulator of Dishevelled in ontogen-
esis) and the closely related Dapper were identified by
virtue of their functional and physical interactions with
the central Wnt pathway component Dishevelled (Dsh)
(Cheyette et al., 2002; Gloy et al., 2002). While each re-
mains incompletely understood, Frodo/Dapper posi-
tively or negatively modulate the Wnt pathway, thus par-
ticipating in multiple developmental processes such as
axis induction, neural development, and morphogenic
movements (Brott and Sokol, 2005; Cheyette et al.,
2002; Gloy et al., 2002; Hikasa and Sokol, 2004; Wax-
man, 2005). Here, we report that Frodo associates with
and stabilizes the p120-catenin protein, enabling p120-
catenin to more effectively relieve Kaiso-mediated
repression. To our knowledge, our findings support a
new function of Frodo, and thereby Dsh and other
upstream Wnt signaling components including Wnt
ligands, in regulating p120-catenin activity within the
p120-catenin/Kaiso pathway. It thus appears that the
Wnt/b-catenin and p120-catenin/Kaiso pathways con-verge at both upstream and downstream points, sug-
gesting considerable functional integration of distinct
catenin subfamily members in development and, con-
ceivably, disease.
Results
Identification of p120-Catenin
as a Frodo-Interacting Partner
With the intent of examining Frodo developmental
mechanisms, yeast two-hybrid assays were performed
by using Frodo as ‘‘bait’’ in conjunction with a Xenopus
gastrula cDNA expression library (Itoh et al., 2000). Re-
sulting positive clones included the carboxy-terminal
half of xp120-catenin, beginning with the sixth repeat
of the central Armadillo domain. This potential interac-
tion was consistent with the partially shared cytoplas-
mic and nuclear subcellular distributions of Frodo and
p120-catenin (Aho et al., 2002; Brott and Sokol, 2005).
To test for the existence of Frodo:p120-catenin inter-
actions in vivo, we performed coimmunoprecipitation
from Xenopus laevis embryo extracts by using anti-
Frodo antibody. This endogenous assay clearly sup-
ported the coassociation of Frodo and p120-catenin
(Figure 1A, lane 3). The reverse endogenous precipita-
tion of p120-catenin, followed by western blot detection
of Frodo, was more difficult to interpret due to the
appearance of background signals (data not shown).
In a partial exogenous expression context, HA-tagged
Frodo (HA-Frodo) mRNA was injected into cleavage-
stage embryos and extracts (obtained at stages 11–12)
employed in coimmunoprecipitation tests. Similar to en-
dogenous Frodo:xp120-catenin coassociation, overex-
pressed HA-Frodo coprecipitated endogenous xp120-
catenin (Figure 1B). Because p120-catenin additionally
binds the Kaiso transcriptional repressor to relieve
Kaiso-dependent gene repression (Kelly et al., 2004b;
Kim et al., 2004; Park et al., 2005; Spring et al., 2005),
we tested whether Frodo is also able to associate with
Kaiso. Coinjection of Myc-Frodo mRNA with either
HA-xp120-catenin or HA-xKaiso mRNA and subsequent
coimmunoprecipitation showed that while p120-catenin
interacts with Frodo as expected based on our above-
described tests, Kaiso repressor does not (Figure 1C,
compare lanes 4 and 6). Next, to characterize Frodo’s in-
teraction domain with p120, we generated a series of
Frodo deletion constructs (a–e) (Figure 1D). Unlike the
previously mapped interaction of Frodo with Dsh (Gloy
et al., 2002), the carboxy-terminal PDZ-binding motif of
Frodo is not required for the Frodo:p120-catenin inter-
action. Rather, the middle region (189–807 amino acids)
of Frodo appears to be the primary region permitting
direct or indirect association with p120-catenin (Figures
1D and 1E). Collectively, these data suggest that Frodo
interacts with p120-catenin in vivo (endogenous or
exogenous expression contexts) and in vitro (yeast
two-hybrid).
Frodo Regulates Kaiso-Dependent
Transcriptional Repression
Several reports have proposed that p120-catenin acts
as a regulator of the Kaiso transcriptional repressor
(Kim et al., 2004; Park et al., 2005; Spring et al., 2005;
van Roy and McCrea, 2005). Based on the association
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685Figure 1. Interaction between p120-Catenin and Frodo
(A) Uninjected embryos were lysed at stages 10–11 and immunoprecipitated with anti-xp120-catenin or anti-Frodo antibody, followed by immu-
noblotting with anti-p120-catenin polyclonal antibody.
(B) HA-Frodo mRNA was injected into each blastomere of two-cell embryos (0.25 ng to each blastomere). Anti-HA immunoprecipitates were
subjected to immunoblotting with anti-xp120-catenin antibody. WCL (whole cell/embryo lysates) served as loading controls.
(C) Either HA-xKaiso or HA-xp120-catenin mRNA (0.25 ng, positive control) was coinjected with Myc-Frodo mRNA (0.25 ng) into both blasto-
meres at the two-cell stage. Anti-Myc immunoprecipitates were immunoblotted with anti-HA antibody and did not resolve a Frodo:Kaiso
complex (lane 6).
(D) Frodo cDNA deletion constructs (a–e). The table indicates the relative association of Frodo deletion constructs with p120-catenin shown in (E).
(E) Frodo deletion constructs (a–e) were coexpressed with HA-xp120-catenin (in vitro-transcribed mRNAs coinjected into one blastomere of
two-cell embryos). Gastrula (stage 12) embryo extracts were subjected to coimmunoprecipitation with IgG (negative control) or anti-HA antibody.
Bottom blots indicate overexpressed Frodo deletion constructs and xp120-catenin in WCL.of Frodo with xp120-catenin, we wished to examine the
impact of Frodo on Kaiso-mediated repression, and
thereby the possible involvement of Frodo in the newly
discovered p120-catenin/Kaiso signaling pathway.
Since it was demonstrated that Kaiso suppresses
xWnt-11 transcription by direct Kaiso:DNA association
(Kim et al., 2004), we first tested whether Frodo overex-
pression (Frodo mRNA injection) or Frodo depletion
(Frodo-morpholino [Frodo-MO] injection) alters xWnt-
11 transcript levels. Employing semiquantitative RT-
PCR (reverse transcriptase-polymerase chain reaction),
it was observed that Frodo depletion reduces endoge-
nous xWnt-11 transcription and, conversely, that Frodo
overexpression raises xWnt-11 transcription (Figure 2A).
To verify the specificity of Frodo’s effects, we used
xWnt-11 reporter plasmids harboring KCS (Kaiso con-
sensus sequence; wild-type KCS, CTGCAA; mutantKCS, CTTCAA [the altered base is underlined]) (Kim
et al., 2004). As expected, while Frodo depletion by
Frodo-MO reduced wild-type KCS-xWnt-11 promoter
activity, it had no effect on the mutant KCS-xWnt-11
promoter construct (Figure 2B). These data suggest
that Frodo specifically contributes to relieving Kaiso-
mediated gene repression.
Owing to the established role of p120-catenin in re-
lieving Kaiso-mediated gene repression, we wished to
test if Frodo’s effects on Kaiso transcriptional activity
might occur through p120-catenin. We therefore tested
the dependency of Frodo’s effects on p120-catenin by
coinjecting Frodo mRNA with p120-catenin-morpholino
(p120-MO), and we evaluated the impact on xWnt-11
mRNA transcript levels by using semiquantitative RT-
PCR of embryo extracts. As shown in Figure 2C (com-
pare lanes 2 and 4), the activation of xWnt-11 mRNA
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injection. Moreover, the derepression of xWnt-11 by
Frodo overexpression is partially diminished by Kaiso
overexpression (Figure 2D, compare lanes 3 and 4). Be-
cause such exogenous Kaiso only modestly counter-
acted Frodo-induced activation of xWnt-11, we asked
if endogenous p120-catenin might have lowered Kaiso’s
impact. We therefore depleted endogenous xp120-
catenin through the coinjection of xp120-catenin-
morpholino (along with Frodo and Kaiso mRNAs) and
assessed xWnt-11 activation. As expected, upon the
Figure 2. Frodo Regulation of the xKaiso Target Gene, xWnt-11
(A) Frodo-morpholino (Frodo-MO, 20 ng) or standard-morpholino
(Std-MO, 20 ng) was injected into both blastomeres at the two-cell
stage (lanes 1–3). Semiquantitative RT-PCR was performed to
detect xWnt-11 and Histone H4 transcripts. Alternatively, either
HA-Frodo mRNA (0.5 ng) or b-galactosidase (b-gal) mRNA (0.5 ng)
was injected for subsequent semiquantitative RT-PCR (lanes 4–6).
(B) Wild-type (WT) versus mutant KCS (mutKCS) xWnt-11 luciferase
reporter plasmid (0.5 ng) was coinjected with Frodo-MO (20 ng). At
stage 12, eight embryos per condition were collected to quantitate
luciferase activity.
(C) Either Myc-Frodo mRNA (0.5 ng) or xp120-catenin-morpholino
(xp120-MO, 20 ng) were coinjected into both blastomeres at the
two-cell stage. To normalize either morpholino or mRNA concentra-
tion across samples, Std-MO or b-gal mRNA was added. The em-
bryos were harvested at stage 11 for semiquantitative RT-PCR.
(D) Either HA-xKaiso (0.5 ng) or Myc-Frodo (0.5 ng) was injected into
one-cell-stage embryos, followed by RNA extraction at stage 11.
(E) Either HA-xKaiso (0.5 ng) or Myc-Frodo (0.5 ng) was coinjected
with xp120-catenin-morpholino (10 ng) into both blastomeres of
embryos at the two-cell stage. Total amounts of either RNA or
morpholino delivered were normalized with GFP mRNA or Std-MO,
respectively. Embryos were collected and processed at stages 11–
12, and RT-PCR was used to asses effects on xWnt-11 transcription.
All semiquantitative RT-PCR was repeated more than three times
with similar outcomes.
Error bars represent the standard deviation from three independent
experiments.depletion of xp120-catenin, exogenous Kaiso exhibited
a more pronounced inhibition of Frodo-induced xWnt-11
activation (Figure 2E, compare lanes 4 and 6). These
results imply that Kaiso-mediated repression of gene
targets is subject to modulation by Frodo together with
p120-catenin, presumably the result of Frodo:p120-
catenin association.
Regulation of Kaiso:Promoter Association by Frodo
It is thought that p120-catenin relieves Kaiso-mediated
transcriptional repression by dissociating Kaiso from
gene control regions and/or by cytoplasmically seques-
tering Kaiso, the latter perhaps via the masking of
Kaiso’s NLS (nuclear localization signal) (Kim et al.,
2004; Park et al., 2005; Spring et al., 2005). However,
unknown at present are the detailed molecular mecha-
nism(s) of p120-catenin’s downstream functions, or until
this report, the identity of upstream stimuli or molecules
that direct p120-catenin’s actions. To address Frodo’s
impact on Kaiso:DNA association, we applied in vivo
chromatin immunoprecipitation (ChIP) assays (Kim
et al., 2004; Park et al., 2005). Although faint due to
the in vivo (whole-embryo) nature of the experiment,
semiquantitative-ChIP-PCR repeatedly indicated Myc-
xKaiso association with the gene promoter of xWnt-11
as well as Siamois (Figure 3A, compare lanes 1 and 2).
Consistent with previous studies (Kelly et al., 2004a;
Kim et al., 2002; Park et al., 2005; Spring et al., 2005),
p120-catenin overexpression with Myc-Kaiso reduced
the latter’s binding to its promoter targets (Figure 3A,
compare lanes 2 and 8), confirming the inhibitory role
of p120-catenin in Kaiso:DNA interactions. While slightly
less pronounced, Frodo overexpression interestingly
also reduced Myc-xKaiso’s association with target pro-
moters (Figure 3A, compare lanes 2 and 5), suggesting
that Frodo likewise inhibits Kaiso:DNA association.
We next asked if diminished Kaiso:DNA association
occurring after p120-catenin overexpression resulted
from the subcellular redistribution of Kaiso in response
to Frodo. For this purpose, we employed immunofluo-
rescent staining of HeLa cells transiently transfected
with HA-Frodo, Myc-xKaiso, and/or HA-xp120-catenin.
As shown in Figure 3B, Kaiso is localized principally to
the nucleus; however, upon p120-catenin cotransfec-
tion, Kaiso is dramatically relocalized to the cytoplasm.
Interestingly, Frodo-cotransfected cells also exhibited
efficient relocalization (Figure 3B, right panel). Since
Frodo induces the nuclear export of Kaiso in the appar-
ent absence of a biochemical Frodo:Kaiso interaction
(see Figure 1C, lane 6), we suspected that Frodo-
induced relocalization of Kaiso might be mediated by the
initial relocalization of p120-catenin by Frodo. Indeed,
upon Frodo overexpression, p120-catenin’s dispersed
pattern became perinuclear and overlapped with that
of Frodo (Figure S1; see the Supplemental Data avail-
able with this article online). It thus appears that Frodo
is capable of altering p120-catenin localization, with
p120-catenin in turn sequestering Kaiso away from the
nucleus (gene promoters) to the cytoplasm.
Frodo Rescues Kaiso-Induced Gastrulation Defects
Previously, we demonstrated that Kaiso-mediated mod-
ulation of xWnt-11 gene activity is essential for proper
convergent extension during early gastrulation (Kim
Frodo Modulation of p120-Catenin/Kaiso Signaling
687et al., 2004; Park et al., 2005). We therefore reasoned
that Frodo may also affect convergent extension
through p120-catenin-mediated regulation of the Kaiso
repressor. Based on our molecular and biochemical ev-
idence that Frodo reduces Kaiso’s repression of gene
targets (see Figures 2 and 3), we tested for in vivo effects
of Frodo on Kaiso in Xenopus early embryogenesis/gas-
trulation. As expected, Kaiso overexpression resulted in
gastrulation defects evident in incomplete blastopore
closure (Figure 4B) and defects in convergent extension
(data not shown) (Park et al., 2005). However, the coin-
jection of Frodo mRNA with Kaiso mRNA resulted in
the partial (w30%) rescue of such gastrulation failure
phenotypes, and this occurred in a dose-dependent
manner (Figures 4C–4E). Additionally, to test whether
endogenous Frodo is required for normal gastrulation,
we depleted it through Frodo-MO injection. Although
the injection of smaller amounts of Frodo-MO did not
result in notable effects, higher doses (20 ng) pro-
duced severe gastrulation failures in a large proportion
(w72%) of embryos relative to controls (Figure 4G).
Our data thus support an essential role of Frodo in early
Figure 3. Inhibition of Kaiso:DNA Association by Frodo
(A) Myc-xKaiso mRNA was coinjected with HA-Frodo or HA-xp120-
catenin mRNA into one-cell embryos (0.5 ng each mRNA). At stage
12, the embryos were processed for ChIP (chromatin immunopre-
cipitation) and semiquantitative PCR by using primers situated on
either side of established KCS within xWnt-11 or Siamois promoter
sequences. The XLMC2 promoter sequence served as a negative
control.
(B) HeLa cells were transiently transfected with Myc-xKaiso, HA-
xp120-catenin, or HA-Frodo as indicated. A total of 24 hr after trans-
fection, cells were fixed, incubated with anti-Myc antibody, and then
visualized by using Texas red-conjugated anti-mouse antibody and
fluorescence microscopy. Hoechst 33258 was used for nuclear
staining.embryogenesis in keeping with earlier reports (Gloy
et al., 2002). Also assessed was Frodo overexpression,
which in a dose-dependent manner produced gastrula-
tion failures in a proportion of embryos (Figure 4F). We
expect that Frodo’s overexpression effects resulted in
part from the activation (relief of repression) of largely
unknown Kaiso repressor gene targets; however, one
known transcriptional target to consider was xWnt-11
(Kim et al., 2004).
To test if Frodo overexpression phenotypes could be
rescued by reducing Wnt/PCP signaling downstream of
xWnt-11, we employed established Dsh-DPDZ and Dsh-
DDEP constructs (Kim et al., 2004; Wallingford et al.,
2000). Since gastrulation failures resulting from the
derepression of xWnt-11 by Kaiso depletion had been
partially rescued by Dsh-DDEP (Kim et al., 2004), we
anticipated it might likewise reduce overexpression
effects of Frodo on Wnt/PCP signaling. Indeed, to a par-
tial (w20%) extent, Dsh-DDEP repeatedly rescued the
Frodo overexpression phenotype (see Figure 4H). This
result was consistent with our previous finding showing
that Dsh-DDEP (but not Dsh-DPDZ) could partially res-
cue the xWnt-11 activation phenotype after Kaiso deple-
tion (Kim et al., 2004). Moreover, we found that the over-
expression of dominant-negative DN-xWnt-11, which
produces convergent-extension failures (Heisenberg
et al., 2000), was fractionally rescued by Frodo mRNA
microinjection; such an effect presumably arose in part
from increased endogenous xWnt-11 expression (data
not shown). Our whole-embryo rescue data (Figures
4C–4E and 4H) support models wherein Frodo acts to
relieve downstream Kaiso gene repression of develop-
mentally important (e.g., xWnt-11) genes modulating
Wnt/PCP signaling.
Frodo Regulates p120-Catenin Protein Stability
Because p120-catenin modulates cadherin function,
we tested if, by association, Frodo has an impact on
cell-cell adhesion. One could imagine, for example,
that Frodo’s effects on adhesion might be coordinated
with those that relieve Kaiso-mediated repression of
gene targets in the nucleus. We assessed Frodo-over-
expressing effects by using standard Xenopus naive
ectoderm (ex vivo animal cap) cell reaggregation as-
says. Frodo overexpression, however, did not obviously
alter cell reaggregation, suggesting that cadherin-medi-
ated cell-cell adhesion is not responsive to Frodo (Fig-
ure S2). A caveat of course is that mild effects may
have escaped detection ex vivo but remain significant
in vivo.
To further examine Frodo:p120-catenin interactions,
but at the metabolic level, we tested whether Frodo de-
pletion produces measurable changes in the level of
p120-catenin within embryos. Indeed, Frodo depletion
(Frodo-MO) resulted in significantly decreased p120-
catenin levels, while, in contrast, the amount of Kaiso
protein remained unchanged (Figure 5A, compare lanes
1 and 3 with lanes 2 and 4). As would be expected for the
specificity of such a response, Frodo-MO-induced loss
of p120-catenin occurred in a dose-dependent manner
(data not shown). To further verify Frodo-MO (Frodo
depletion) specificity in reducing p120-catenin levels,
we performed rescue experiments in which Frodo-MO
and Myc-Frodo mRNA were coinjected. As anticipated,
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688Figure 4. Frodo Partially Rescues Kaiso-
Induced Gastrulation Failures
(A–D) xKaiso mRNA (0.5 ng) was coinjected
with Frodo mRNA (0.0625/‘‘+’’ ng or 0.25/
‘‘++’’ ng) into one-cell embryos (total mRNA
normalized to 0.75 ng with b-gal mRNA).
Gastrulation defects were visually scored at
stages 10–12. Among three independent
experiments, representative vegetal-pole
images are displayed (dashed lines indicate
blastopores).
(E) Quantitation of gastrulation-failure pheno-
types.
(F) Prior to conducting rescue experiments,
the impact of delivering varying doses of
Frodo mRNA into one-cell embryos was
determined.
(G) Increasing doses of Frodo-MO versus
Std-MO were injected into one blastomere
at the two-cell stage, and embryos were
scored for defects at late gastrulation (stage
12.5).
(H) Frodo mRNA (2.0 ng) was coinjected with
Dsh-DDIX, Dsh-DPDZ, or Dsh-DDEP into one
blastomere of two-cell-stage embryos, and
gastrulation-rescue effects were scored
(250 pg each; GFP serving as the negative
control).
Error bars represent the standard deviation
from three independent experiments.exogenous Frodo expression significantly (if not com-
pletely) recovered endogenous p120-catenin levels in
a dose-dependent manner (Figure 5B). To widen our
understanding of Frodo-like proteins in modulating
p120-catenin protein levels, we also tested the effect of
injecting a Dapper-morpholino (Dapper-MO). Dapper is
a member of the Frd (Frodo/Dapper) protein family,
and, similar to Frodo, interacts with Dsh protein (Chey-
ette et al., 2002). Although Frodo’s and Dapper’s roles
in Wnt signaling are incompletely understood and may
each include both positive and negative roles (Cheyette
et al., 2002; Gloy et al., 2002), we observed that the
depletion of either Frodo or Dapper in embryos resulted
in decreased p120-catenin protein levels, with the
Frodo-MO having the greater effect (Figure 5C). These
results imply that Frodo and Dapper may have a com-
mon role in regulating p120-catenin protein levels.
Since p120-catenin’s association with Kaiso acts
to relieve Kaiso-dependent transcriptional repression
(Kelly et al., 2004a; Kim et al., 2004; Park et al., 2005;
Spring et al., 2005), alterations in p120-catenin protein
levels in response to Frodo would be expected to have
an impact on Kaiso gene targets (Figures 2 and 3). To
test if p120-catenin:Kaiso association responds to Frodo
levels, we coinjected Frodo mRNA versus Frodo-
MO together with Myc-xp120-catenin and HA-xKaiso
mRNAs (three-component injection). Subsequently, ex-
tracts from gastrula-stage (stage 11) embryos were as-
sessed for HA-xp120-catenin:Myc-xKaiso association.
Those embryos overexpressing Frodo (as opposed tob-galactosidase) demonstrated a reproducible increase
in p120-catenin:Kaiso interactions (Figure 5D, compare
lanes 6 and 8). Conversely, Frodo depletion (Frodo-
MO) resulted in diminished p120-catenin:Kaiso associa-
tions (Figure 5D, compare lanes 2 and 4), apparently due
to lowered levels of p120-catenin protein (Figure 5D,
compare lanes 2 and 4 within the xp120-catenin western
blot). Alternatively, when concanavalin A was used to
precipitate glycoprotein complexes (such as cadherin),
both the cadherin- and residual cytosolic-enriched
fractions showed partial but reproducible increases in
p120-catenin levels in response to Frodo overexpres-
sion (Figure 5E, lanes 2 and 4). These and the above-
mentioned data suggest that Frodo positively affects
p120-catenin protein levels, relieving Kaiso-mediated
gene repression.
Wnt Signaling Is Involved in Frodo-Dependent
p120-Catenin Protein Stabilization
Given that Frodo was initially identified as a Dsh-inter-
acting protein in the Wnt/b-catenin signaling pathway
(Gloy et al., 2002), we reasoned that Dsh might play
a role in Frodo-mediated regulation of p120-catenin pro-
tein levels. Overexpression of Dsh resulted in modest
but reproducible increases in p120-catenin protein as
assessed through band-density quantification of ECL/
western blots (Figure 6A). We then additionally evalu-
ated the impact of established Dsh mutants (Dsh-
DDIX, DPDZ, and DDEP) on p120-catenin protein levels,
since these constructs have somewhat differential
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Catenin Protein while Frodo Overexpression
Stabilizes p120
(A) Either HA-xKaiso mRNA (0.25 ng) or HA-
xp120-catenin mRNA (0.25 ng) and morpho-
lino (10 ng Frodo-MO or Std-MO) were coin-
jected into both cells of two-cell embryos.
Embryos were harvested at stages 11–12 for
immunoblotting with anti-HA antibody. Actin
was used as an internal loading control from
whole cell/embryo extracts. The brackets
marked ‘‘1’’ and ‘‘2’’ indicate results from
two independent sets of embryos.
(B) Increasing amounts of Myc-Frodo mRNA
(0.1 and 0.5 ng) were coinjected with Frodo-
MO and HA-xp120-catenin mRNA (0.25 ng)
into one blastomere at the two-cell stage.
Embryos were harvested for immunoblot
analysis of Myc-Frodo-generated rescues at
stages 11–12.
(C) HA-xp120-catenin mRNA (0.25 ng) was
coinjected with Frodo-MO (10 ng) or Dap-
per-MO (10 ng) into one blastomere at the
two-cell stage, followed by immunoblot as-
sessment of xp120-catenin levels in embryo
extracts (stage 12).
(D) Morpholino (10 ng of Std-MO or Frodo-
MO; lanes 1–4) or mRNA (0.25 ng of b-gal or
Frodo mRNA) were coinjected with both
Myc-xp120-catenin and HA-xKaiso mRNA
(0.2 ng each) into one blastomeres at the
two-cell stage. Embryos were collected at
stage 11 (40 embryos per condition) and
were used for immunoprecipitation/immuno-
blot analysis to assess Myc-xp120-catenin:HA-xKaiso association (using anti-HA antibody). WCL indicated equivalent expression of Myc-
xp120-catenin as well as HA-xKaiso protein.
(E) Myc-Frodo mRNA (0.5 ng) was injected into the animal region of both blastomeres at the two-cell stage. At stages 10–11, embryos were lysed
and incubated with concavanalin A (Con-A) beads for 30 min to precipitate cadherin-associated (glycosylated) protein complexes. After brief
centrifugation, the pellet (ConA. pull-down fraction) and the supernatant (ConA. depleted fraction) were applied as equal fractions and subjected
to SDS-PAGE/immunoblotting.effects on Wnt/b-catenin versus Wnt/PCP pathways. In-
terestingly, Dsh-DDIX expression resulted in decreased
p120-catenin presence (Figure 6B, lane 2). Given the
Dsh-DIX domain’s role in transducing Wnt/b-catenin
signals, and in associating with Frodo (Gloy et al.,
2002; Rothbacher et al., 2000), these data imply that
Dsh:Frodo interactions modulate cellular p120-catenin
levels. Next, to assess Dsh and Frodo epistasis in regu-
lating p120-catenin, we tested whether lowered p120-
catenin levels seen after Dsh-DDIX expression could
be rescued by Frodo overexpression. Since Dsh and
perhaps Frodo have scaffolding functions, a caveat is
that such functional epistasis results would not neces-
sarily reflect clear distinctions in the sequence of the
components’ associations. Nonetheless, as shown in
Figure 6C, Frodo overexpression suppresses the effect
of Dsh-DDIX in reducing p120-catenin protein levels
(compare lanes 2 and 4), suggesting that Frodo is
functionally downstream of Dsh.
One of the remaining puzzles is the means by which
native Dsh and Frodo produce a positive effect on
p120-catenin protein levels. Based on current models
of how b-catenin protein levels are regulated via Dsh and
a multicomponent destruction complex (Logan and
Nusse, 2004; Moon et al., 2004), we hypothesized that
p120-catenin may also undergo proteasome-mediated
degradation. Indeed, when incubated with the 26S
proteasome inhibitor MG132 (50 mM), p120-cateninlevels were no longer reduced in embryos expressing
Dsh-DDIX (Figure 6D). Analogously, while not graphic,
p120-catenin metabolic turnover was at least partially
reduced in Frodo-depleted embryos incubated in the
presence of MG132 (Figure 6E).
Because GSK3b has a role in regulating b-catenin pro-
tein stability in response to Wnt signals (Liu et al., 2002;
Polakis, 2002), we investigated its possible involvement
with regard to p120-catenin. Endogenous p120-catenin
levels were increased in a dose-dependent manner in
mammalian MCF-7 and HeLa cell lines treated with up
to 25 and 50 mM LiCl, a GSK3b inhibitor (Klein and
Melton, 1996) (Figure 6F). At higher LiCl doses (100
mM), decreased p120-catenin levels were observed,
perhaps resulting from cytotoxicity. Based on the partic-
ipation of Dsh and Frodo in regulating p120-catenin pro-
tein levels/stability (also see Figures 5A, 6A, and 6B), we
wished to test if the Wnt ligand itself affected p120-
catenin protein levels. To activate the Wnt/b-catenin
signaling pathway, we expressed xWnt-8 (activates
Wnt/b-catenin) versus xWnt-5a (activates Wnt/PCP) in
early embryos and assessed their respective effect on
p120-catenin protein.
Embryonic overexpression of xWnt-8, but not xWnt-
5a, resulted in modest increases in xp120-catenin pro-
tein levels, which were reproducible, although less than
those observed (and expected) for b-catenin (Figure 6G).
In contrast, in a mammalian cell line context, Wnt-3A
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(A) Myc-Dsh mRNA (0.5 ng) was coinjected with HA-xp120-catenin mRNA (0.25 ng) into both blastomeres at the two-cell stage, and gastrulating
embryos (stage 12) were collected for immunoblot analysis. The asterisk indicates what is likely to be a proteolytic degradation product
of HA-xp120-catenin that is reproducibly less apparent upon Myc-Dsh cooverexpression. Quantitation of the relative band density of
HA-xp120-catenin is indicated.
(B) A total of 0.5 ng Dsh deletion mutant mRNAs (DDIX, DPDZ, and DDEP) were utilized for coinjection with Myc-xp120-catenin mRNA (0.25 ng)
into the dorsal animal region of two blastomeres (arrows indicate injection area) at the four-cell stage. At stage 12, embryos were harvested and
lysates were immunoblotted with anti-Myc antibody. The b-catenin immunoblot served as a positive control for Dsh deletion mutant effects.
(C) Frodo abrogates the effect of Dsh-DDIX on p120-catenin protein stability. Each mRNA (0.5 ng Frodo and/or Dsh-DDIX) was coinjected with
Myc-xp120-catenin mRNA (0.5 ng) into two blastomeres at the four-cell stage. Embryos were harvested at stage 12, and the level of Myc-xp120-
catenin protein was assessed by immunoblot.
(D) Either Myc-xp120-catenin mRNA (0.5 ng) or Dsh-DDIX mRNA (0.5 ng) was injected into both blastomeres at the two-cell stage, followed by
immediate treatment with MG132 (50 mM) or DMSO (negative control). Embryos were collected at stages 11–12 for subsequent immunoblot with
anti-Myc antibody to detect Myc-xp120-catenin.
(E) Embryos injected with HA-xp120-catenin mRNA (0.5 ng) and with either Std-MO or Frodo-MO (20 ng) (coinjections into one blastomere at the
two-cell stage) were immediately treated with varying concentrations of MG132 and later harvested at stages 11–12 for immunoblotting.
(F) MCF-7 mammalian cells were treated with the GSK3b inhibitor LiCl (5, 10, 25, 50, 100 mM) for 24 hr. Endogenous p120-catenin protein levels
were analyzed by immunoblotting for p120-catenin. b-catenin protein served as a positive control for LiCl treatment.
(G) Increased p120-catenin protein by Wnt ligand. Either xWnt-8 or xWnt-5a mRNA (0.5 ng) was coinjected with HA-xp120-catenin mRNA into
both blastomeres at the two-cell stage. At stage 12, the embryos were collected for further immunoblotting with anti-HA antibody.
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failed to increase endogenous p120-catenin protein
within HEK293 monolayers (data not shown). Thus, while
not evident in all experimental systems, our in vivo
(embryo) data suggest that an upstream Wnt ligand
(xWnt-8) has the capacity to modestly raise p120-
catenin protein levels.
Since the xWnt-8 induced increase in p120-catenin
protein levels would be expected to promote p120’s
capacity to sequester Kaiso away from gene promoters,
we tested the effects of xWnt-8 on Kaiso:promoter-DNA
association by using ChIP assays. As expected, xWnt-8
expression lessened Kaiso binding to two of its known
target gene promoters, xWnt-11 and Siamois (Figure S3,
compare lanes 2 and 5).
Finally, at the biochemical level, we employed immu-
noprecipitation and in vitro binding assays to test if
Dsh directly associates with p120-catenin (Figures 6H
and 6I). While the expected direct interaction of p120-
catenin with Frodo (see Figure 6I, lane 7), as well as
that of p120-catenin with Kaiso (lane 6), was resolved,
a direct interaction between Dsh and p120-catenin
was not supported. Together, our results indicate that
p120-catenin is metabolically stabilized in response to
Wnt ligands through the involvement of Dsh and Frodo.
Further, our data are consistent with the possibility that
GSK3b-mediated phosphorylation of p120-catenin may
modulate p120-catenin’s (proteasomal and/or other)
degradation/stability, and thereby its signaling capacity
within the recently described p120-catenin/Kaiso devel-
opmental pathway.
Discussion
Frodo: Upstream Modulator of the
p120-Catenin/Kaiso Signaling Module
Since p120-catenin associates with cadherin membrane-
proximal domains in manners responsive to phosphory-
lation (Ohkubo and Ozawa, 1999; Skoudy et al., 1996;
Thoreson et al., 2000), it is conceivable that plasma
membrane- or cytoplasmically associated kinases or
phosphatases have an impact on the entry of p120-
catenin into a signaling/nuclear pool involving Kaiso.
However, even in normal cells, p120-catenin is often not
solely localized to cadherin-enriched cell-cell borders
(Aho et al., 2002; van Hengel et al., 1999); thus, other
possibilities must be considered as potential upstream
regulators of the p120-catenin/Kaiso pathway (Figure 7).
Here, we identified Frodo as interacting with p120-
catenin both in vitro and in vivo, and we have also shown
Frodo to have an impact on Kaiso-mediated transcrip-
tional repression. Frodo was initially identified in associ-
ation with the DIX domain of Dsh, and, as might be antic-
ipated given such a physical interaction, was found tomodulate Wnt/b-catenin signaling (Gloy et al., 2002).
We tested and found that upstream Wnt pathway com-
ponents such as Dsh also have an impact on the p120-
catenin/Kaiso developmental pathway. Indeed, given
our previous finding that certain Wnt/b-catenin gene tar-
gets are coregulated by b-catenin/TCF and p120-cate-
nin/Kaiso signals (Park et al., 2005), these two pathways
appear to be integrated at upstream as well as down-
stream (promoter) levels and may act in a coupled and
parallel fashion to generate more robust effects in
some contexts.
In considering p120-catenin’s larger roles, we cannot
rule out additional signaling outputs that may or may not
be independent of its effects examined here. For exam-
ple, there is strong evidence that p120-catenin modu-
lates Rho GTPase activity as well as cadherin stability
(Anastasiadis and Reynolds, 2001; Davis et al., 2003),
both apt to have significant downstream effects. p120-
catenin has recently been implicated to regulate NF-kB
signaling through Rho/ROCK (Perez-Moreno et al.,
2006) and to modulate cell proliferation (Davis and Rey-
nolds, 2006). Thus, in the future, the impact of Frodo
(through p120-catenin) on Rho GTPase and other path-
ways will have to be considered. As an initial approach
to this question, we observed that Frodo inhibits Rho ac-
tivity (see Figure S4), which presumably occurs through
the promotion of p120-catenin levels/function. There-
fore, we are again reminded of inaccuracies that might
arise when attempting to conceptually separate Wnt/b-
catenin and Wnt/PCP pathway trajectories. That is, we
have shown that Wnt/b-catenin signals previously es-
tablished to involve the Dsh-DIX domain (and in some
cases Frodo) engage the downstream actions of p120-
catenin in addition to b-catenin. Even though Rho
GTPases are more often viewed as mediators of Wnt/
PCP pathways, our results suggest that, through p120-
catenin, Rho GTPase functions may conceivably be
modulated downstream of ‘‘canonical Wnt’’ signals as
well.
How Frodo Stabilizes p120-Catenin
The means by which Frodo modulates Kaiso repressor
activity may occur in more than one way. In addition to
its noted interaction with Dsh, Frodo has been impli-
cated in associating with nuclear TCF-3. It is con-
ceivable that nuclear Frodo positively influences p120-
catenin function at gene control regions (enhancing
displacement of Kaiso from DNA?), especially as TCF
and Kaiso themselves associate (Park et al., 2005).
Another possibility is that the Frodo:p120-catenin com-
plex enhances p120-catenin’s capacity to sequester
Kaiso from the nucleus in relieving Kaiso-mediated gene
repression. While not exclusive of either possibility, we
observe that Frodo depletion reduces p120-catenin(H) Xenopus embryos were microinjected with either Myc-Dsh or HA-xp120-catenin mRNA into both cells at the two-cell stage. Injected embryos
were harvested at stage 12, and either Myc-Dsh or HA-xp120-catenin was immunoprecipitated by using anti-HA or Myc antibody. Both Myc-
tagged Dsh protein and HA-xp120-catenin were detected within HA-xp120-catenin and Myc-Dsh precipitates, respectively (upper blots, lanes
8 and 16). Immunoprecipitation of either HA-xp120-catenin or Myc-Dsh was successful (positive control, lanes 4 and 12). Coimmunoprecipiation
of negative controls showed little or no signals (lanes 2, 6, 10, and 14). Bottom blots of whole cell/embryo extracts indicate the faithful overex-
pression of Myc-Dsh and HA-xp120-catenin.
(I) Direct association of p120-catenin with Frodo, but not Dsh. In vitro-translated HA-xp120-catenin, Myc-xKaiso, Myc-Frodo, and Myc-Dsh
proteins were incubated at 4C for 30 min and precipitated with anti-HA antibody. The coimmunoprecipitates were analyzed by immunoblotting
with anti-HA and anti-Myc antibody. The results shown are representative of three independent experiments. The scores below selected ECL/
western blots indicate the relative ratios of band intensities normalized to actin loading controls.
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Kaiso Signaling Module in Relation to Wnt Li-
gand Activation of Frizzled/LRP Coreceptor
(A) In the absence of Wnt ligand, the b-catenin
destruction complex (APC, Axin, and GSK3b)
promotes the degradation of b-catenin. p120-
catenin is also subject to degradation in
a GSK3b- and proteasome-modulated man-
ner. In the reduced presence of b-catenin or
p120-catenin signaling pools, TCF/LEF and
Kaiso function more effectively as repressors
within the nucleus.
(B) In the presence of Wnt ligand, signals are
relayed from Frizzled receptor and LRP core-
ceptor to Dsh. Subsequently, Dsh inhibits the
b-catenin destruction complex such that b-
catenin is more likely to enter the nucleus to
relieve repression conferred by TCF/LEF
(gene activation). Simultaneously, activated
Dsh interacts with Frodo through the Dsh-
DIX domain and recruits and stabilizes
p120-catenin. By an unknown means, 120-
catenin is thought to enter the nucleus to as-
sociate with nuclear Kaiso, resulting in the
derepression of Kaiso target genes, some of
which are shared with TCF/LEF (not shown).protein stability while Frodo overexpression enhances it.
Moreover, Dapper, another Frd family protein, appears
to positively regulate p120-catenin protein stability in the
manner of Frodo, even though Frodo and Dapper may
have complex roles in Wnt/b-catenin signaling (Cheyette
et al., 2002; Gloy et al., 2002). When considering prior
work on catenin proteins dissociated from cadherins,
b-catenin has appeared more labile than p120-catenin
in the absence of Wnt/b-catenin signals (Aberle et al.,
1997; Logan and Nusse, 2004; Moon et al., 2004). How-
ever, we have found that lowered p120-catenin stability
after Frodo depletion could be partially restored by
MG132 treatment, suggesting that p120, like b-catenin,
is subject to proteasomal degradation in response to
Wnt signals. Other unknown mechanism may also regu-
late p120-catenin stability. For example, a recent report
has documented Dapper-mediated lysosomal degrada-
tion of Nodal receptors and Dsh (Zhang et al., 2004,2006).
Concerning mechanisms that might regulate p120-
catenin stability, we took note of specific serine residues
present within xp120-catenin’s amino terminus. By
comparing the amino acid sequences of p120-catenin
across other animal species (analyzed by NetPhos 2.0
server, see http://www.cbs.dtu.dk/services/NetPhos/
[Blom et al., 1999]), we identified three evolutionarily
conserved consensus target sequences for GSK3b.
Such motifs are also present in b-catenin’s amino termi-
nus, and, when phosphorylated, they promote recogni-
tion by a large destruction complex (Axin, APC, and
GSK3b) that ultimately results in b-catenin’s proteaso-
mal degradation. Although it was previously reported
that p120-catenin does not associate with APC (Daniel
and Reynolds, 1999), we find it intriguing that the
Frodo-like Dapper has been noted to associate with
GSK3b (Cheyette et al., 2002). It thus remains possible
that GSK3b modulates p120-catenin stability in re-
sponse to Wnt or other upstream signals, with additional
mechanisms also having an impact on p120’s signal
tranduction capacity (Aho et al., 2002; van Hengel
et al., 1999; Xia et al., 2006).Frodo Links the Wnt/b-Catenin/TCF
and p120-Catenin/Kaiso Pathways
Frodo is a positive regulator of the Wnt/b-catenin/TCF
pathway at least in part via interactions with the DIX do-
main of Dsh (Gloy et al., 2002). Perhaps through Frodo,
we additionally find that p120-catenin associates with
Dsh (see Figure 6H). Since p120-catenin’s levels de-
crease upon overexpression of Dsh-DDIX (an inhibitory
Dsh mutant), with exogenous Frodo rescuing this effect,
we believe that Wnt/b-catenin signals may modulate
p120-catenin protein stability through Dsh:Frodo func-
tional interactions. Conceivably, Frodo’s serine-rich re-
gion (following its putative leucine zipper-like domain)
is subject to kinase/phosphatase modulation in re-
sponse to Wnt signals, determining Frodo’s interaction
with and stabilization of p120-catenin.
In our previous study, the p120-catenin/Kaiso and b-
catenin/TCF pathways were shown to coordinately reg-
ulate certain Wnt/b-catenin target genes that harbor
both Kaiso- and TCF-binding sites within their proximal
promoters (Park et al., 2005). Together, our work here
characterizes Frodo as a binding mate and regulator of
p120-catenin, promoting p120-catenin stability and as-
sociation with Kaiso, and thereby the relief of Kaiso-me-
diated gene repression. Thus in addition to Frodo’s role
as a Dsh (and TCF)-interacting protein, we point to it be-
ing a molecule that interrelates the p120-catenin/Kaiso
and b-catenin/TCF signaling pathways downstream of
Wnt/b-catenin stimuli. While b-catenin and p120-catenin
have distinct cellular and developmental roles in a num-
ber of known contexts, our data point to novel shared
functional associations of these two catenins belonging
to different catenin subclasses.
Experimental Procedures
Yeast Two-Hybrid Screening
A Xenopus gastrula-stage cDNA expression library was constructed
as indicated in the yeast pJG4-5 vector (Itoh et al., 2000). The
pEG202 ‘‘bait’’ vector contained a fusion of the LexA DNA binding
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tors were transformed into the EGY48 yeast strain, and colonies
were selected for growth in leucine-free medium and on X-gal-con-
taining plates as described (Gyuris et al., 1993).
Embryo Culture, Microinjections, and In Vitro Transcription
Fertilization, embryo culture, and microinjections were performed in
accordance with standard methods (Fang et al., 2004). Embryos
were microinjected with capped mRNA synthesized in vitro (mMes-
sage mMachine, Ambion) or with morpholino. All pCS2-based con-
structs were linearized by using NotI prior to in vitro transcription.
In some experiments, the proteasomal inhibitor MG132 (Calbio-
chem) was present in standard 0.13 MMR incubation buffer (10
mM NaCl, 0.2 mM KCl, 0.2 mM CaCl2, 0.1 mM MgCl2, 0.5 mM HEPES
[pH 7.4]). Gastrulation phenotypes were visually scored at embry-
onic stages 11–12 (late gastrulation).
Antisense Oligonucleotides
xp120-catenin-morpholino (xp120-MO), Frodo-morpholino (Frodo-
MO), xKaiso-morpholino (xKaiso-MO), Dapper-morpholino (Dap-
per-MO), and standard control-morpholino (Std-MO) were used as
described previously (Cheyette et al., 2002; Fang et al., 2004; Gloy
et al., 2002; Kim et al., 2004).
Constructs
Standard recombinant DNA techniques were used to construct
pCS2 plasmids harboring Myc-xKaiso, HA-xKaiso, HA-xp120-cate-
nin, and Myc-xp120-catenin. Generated previously were pCS2 plas-
mids harboring Myc-Dsh, Dsh-DDIX, Dsh-DPDZ, Dsh-DDEP, and
HA-Frodo-pXT7 (Gloy et al., 2002; Park et al., 2005). Myc-Frodo-
pCS2 was constructed by PCR amplification of HA-Frodo-pXT7 as
a template with the following primers: Frodo-F-EcoRI, 50-GGAATTC
CAGCTCCGCCTCACCCCC-30; Frodo-R-XbaI, 50-GCTCTAGATCAA
ACTGTTGTCATCAGCTTTAA-30. The EcoRI/XbaI-digested PCR
product was subcloned into the 63 Myc (epitope tag) pCS2 vector
(pCS2-MT). Frodo deletion constructs (A–E) were generated by
using endogenous BamHI, PstI, and BglII restriction enzyme sites,
followed by ligation into the pCS2-MT vector.
Reverse Transcription and Semiquantitative PCR
Total RNA was extracted from Xenopus embryos by using Trizol
(Invitrogen) according to the manufacturer’s instructions. To detect
xWnt-11 and Histone H4 transcript levels, cDNA was generated
from 1 mg total RNA by using Superscript (Life Technologies, Inc.)
reverse transcriptase as described by the manufacturer. PCR primer
pairs were as described previously (Kim et al., 2004; Park et al.,
2005).
Reporter Assays
Both wtKCS-xWnt-11 and mutKCS-xWnt-11 reporter vectors were
used for luciferase assays as described (Kim et al., 2004). Briefly, re-
porter plasmid (0.5 ng) was coinjected with morpholino (20 ng) into
the animal region of both blastomeres of two-cell embryos. Gener-
ally, three pools of eight embryos each were collected at gastrula
(10.5)-stage and homogenized in 160 ml passive lysis buffer (Prom-
ega). Luciferase activities were determined from 20 ml embryo ly-
sates by using the Luminoscan Ascent luminometer (Labsystems),
and experiments were repeated three times.
Chromatin Immunoprecipitation Assays
Chromatin immunoprecipitation assays were performed from Xeno-
pus embryo extracts as described (Park et al., 2005). Anti-Myc anti-
body (9E10) was used to precipitate the protein:chromatin com-
plexes. For semiquantitative chromatin immunoprecipitation
(ChIP)-PCR, primer pairs were as previously described to detect
xWnt-11, Siamois, and xLMC2 promoter fragments (Kim et al.,
2004; Park et al., 2005).
Immunoprecipitation, Immunoblot, and In Vitro Translation
Monoclonal or polyclonal antibodies were employed to detect Myc-
epitope (9E10), HA-epitope (12CA5), xp120-catenin (Fang et al.,
2004), b-catenin (Montross et al., 2000), C-cadherin (Fang et al.,
2004), p120-catenin (15D2, kindly provided by Al Reynolds), and
Actin (Sigma). The anti-Frodo polyclonal antibody serum wasobtained from rabbits immunized with GST-Frodo (amino acids
151–328). The serum was then depleted of anti-GST antibodies by
using a GST column and anti-Frodo antibodies affinity purified by
using the same GST-Frodo protein attached to AminoLink sephar-
ose beads. For immunoprecipitation, whole-embryo lysates were
prepared by using modified RIPA buffer (50 mM Tris-HCl [pH 7.4],
1% NP-40, 0.25% Na-deoxycholate, 150 mM NaCl, 1 mM EDTA,
1 mM PMSF, 1 mM Na3VO4, 1 mM NaF, and 1 mg/ml each of Aproti-
nin, leupeptin, and pepstatin). All procedures were performed as
described (Fang et al., 2004). For immunoblotting, procedures
were performed as described. In brief, embryos were collected
and lysed in 20 ml per embryo of 0.5% Triton X-100 buffer (0.5%
Triton X-100, 10 mM HEPES [pH 7.4], 150 mM NaCl, 2 mM EDTA,
2 mM EGTA), inclusive of a proteinase inhibitor cocktail (Sigma).
After centrifugation (14,000 rpm, 5 min), supernatant fractions were
denatured with 43 SDS sample buffer (200 mM Tris-Cl [pH 6.8], 40%
glycerol, 8% SDS, 200 mM DTT, 0.08% Bromophenol Blue), followed
by boiling at 95C for 5 min. A half-embryo equivalent was resolved
by SDS-PAGE and transferred onto nitrocellulose membrane. For
immunoblot blocking and antibody incubation, 2% bovine serum
albumin-TBST (25 mM Tris-HCl [pH 8.0], 125 mM NaCl, 0.5% Tween
20) was used. Finally, SuperSignal WestPico (Pierce Biotechnology,
Inc.) reagents were employed to detect HRP (horseradish peroxi-
dase)-conjugated secondary antibodies. For in vitro translation
(Promega), 1.0 mg of each mRNA (HA-xp120-catenin, Myc-xKaiso,
Myc-Frodo, or Myc-Dsh) was used with 35 ml rabbit reticulocyte
lysate. For protein:protein interaction tests, 10 ml of each solution
was mixed for 30 min at 4C. Precipitations employed anti-HA anti-
body, and coimmunoprecipitates were visualized by immunoblot-
ting. Quantitatation of ECL/western blots was conducted by using
ImageQuant software.
Mammalian Cell Culture and Immunofluorescence Microscopy
The HeLa cell line was purchased from ATCC and was maintained
with Dulbecco’s modified Eagle’s medium containing 10% fetal bo-
vine serum. For immunofluorescence staining, transiently trans-
fected cells on chamber slides were fixed with 100% methanol
and blocked with 2% BSA (bovine serum albumin)-PBS for 1 hr.
The cells were incubated with either anti-HA or anti-Myc monoclonal
antibody for 1 hr, washed with PBS, and further incubated with
Texas red-conjugated secondary antibody (Santa Cruz Biotechnol-
ogy, Inc). For nuclear staining, Hoechst 33258 (0.5 ng/ml, Vector
Laboratories) was used. Finally, cells were observed with fluores-
cence microscopy (Leica, LB30S), and images were recorded by
using SPOT advanced software.
Supplemental Data
Supplemental data include evidence of p120-catenin intracellular
redistribution upon Frodo overexpression, lack of Frodo over-
expression effects on cell-cell reaggregation, Wnt-ligand-induced
reduction of Kaiso:DNA association, and reduction in the level of
activated (GTP-bound) Rho GTPase after Frodo overexpression and
are available at http://www.developmentalcell.com/cgi/content/full/
11/5/683/DC1/.
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